Expert Opinion on Therapeutic Patents, Volume 33, Issue 7-8 (2023)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Therapeutic Patents, Volume 33, Issue 7-8 (2023)

See all volumes and issues
Vol 34, 2024 Volume 33, 2023 Vol 32, 2022 Vol 31, 2021 Vol 30, 2020 Vol 29, 2019 Vol 28, 2018 Vol 27, 2017 Vol 26, 2016 Vol 25, 2015 Vol 24, 2014 Vol 23, 2013 Vol 22, 2012 Vol 21, 2011 Vol 20, 2010 Vol 19, 2009 Vol 18, 2008 Vol 17, 2007 Vol 16, 2006 Vol 15, 2005 Vol 14, 2004 Vol 13, 2003 Vol 12, 2002 Vol 11, 2001 Vol 10, 2000 Vol 9, 1999 Vol 8, 1998 Vol 7, 1997 Vol 6, 1996 Vol 5, 1995 Vol 4, 1994 Vol 3, 1993 Vol 2, 1992 Vol 1, 1991
Download citations Download PDFs Download issue

Patent Evaluation

Review Article
Conjugates of monocyclic β-lactams and siderophore mimetics: a patent evaluation (WO2023023393)
Alen Krajnc & Stanislav Gobec
Pages: 471-476
Published online: 06 Nov 2023
AbstractforConjugates of monocyclic β-lactams and siderophore mimetics: a patent evaluation (WO2023023393) | Full Text | References | PDF (3.3 MB) | EPUB
  • 878 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Patenting Perspective

The next generation of EGFR inhibitors: a patenting perspective of PROTACs based EGFR degraders
Pengyun Li, Bingkun Li, Ning Yang, Tingting Xu & Zhibing Zheng
Pages: 477-492
Published online: 06 Nov 2023
AbstractforThe next generation of EGFR inhibitors: a patenting perspective of PROTACs based EGFR degraders | Full Text | References | PDF (9.9 MB) | EPUB
  • 317 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
CDC7 kinase inhibitors: a survey of recent patent literature (2017–2022)
Takayuki Irie & Masaaki Sawa
Pages: 493-501
Published online: 06 Nov 2023
AbstractforCDC7 kinase inhibitors: a survey of recent patent literature (2017–2022) | Full Text | References | PDF (629.5 KB) | EPUB
  • 188 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update
Carolin Jaworski, Petar Iliev, Carmen Wängler, Björn Wängler, Brent Page, Ralf Schirrmacher & Justin J. Bailey
Pages: 503-521
Published online: 06 Nov 2023
AbstractforType I inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update | Full Text | References | PDF (22.4 MB) | EPUB
  • 189 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
An updated patent review of metallo-β-lactamase inhibitors (2020–2023)
Elsa Denakpo, Thierry Naas & Bogdan I. Iorga
Pages: 523-538
Published online: 06 Nov 2023
AbstractforAn updated patent review of metallo-β-lactamase inhibitors (2020–2023) | Full Text | References | PDF (4.6 MB) | EPUB
  • 288 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease: a patent review of the literature to date
Margaux Morez et al.
Review Article | Published online: 18 Jul 2024
A patent review of small molecule CDK4/6 inhibitors in the treatment of cancer: 2020–present
Xiaoling Huang et al.
Review Article | Published online: 17 Jul 2024
Progress with polo-like kinase (PLK) inhibitors: a patent review (2018–present)
Shirong Bian et al.
Review Article | Published online: 15 Jul 2024
The therapeutic potential of phosphodiesterase 9 (PDE9) inhibitors: a patent review (2018-present)
Chen Zhang et al.
Review Article | Published online: 9 Jul 2024
View all latest articles